Global Psoriasis Drugs Market Growth (Status and Outlook) 2024-2030

September 2024 | 83 pages | ID: G812F547F739EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Psoriasis Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Psoriasis Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global Psoriasis Drugs market. Psoriasis Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Psoriasis Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Psoriasis Drugs market.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Key Features:

The report on Psoriasis Drugs market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Psoriasis Drugs market. It may include historical data, market segmentation by Type (e.g., Tumor Necrosis Factor Inhibitor, Interleukin Inhibitors), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Psoriasis Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Psoriasis Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Psoriasis Drugs industry. This include advancements in Psoriasis Drugs technology, Psoriasis Drugs new entrants, Psoriasis Drugs new investment, and other innovations that are shaping the future of Psoriasis Drugs.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Psoriasis Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Psoriasis Drugs product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Psoriasis Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Psoriasis Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Psoriasis Drugs market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Psoriasis Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Psoriasis Drugs market.

Market Segmentation:

Psoriasis Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type

• Tumor Necrosis Factor Inhibitor
• Interleukin Inhibitors
• Others

Segmentation by application

• Topicals
• Systemic
• Biologics

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AbbVie
• Amgen
• Johnson & Johnson
• Novartis
• Eli Lilly & Company
• AstraZeneca
• Celgene Corporation
• UCB
• Merck

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Psoriasis Drugs Market Size 2019-2030
  2.1.2 Psoriasis Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Psoriasis Drugs Segment by Type
  2.2.1 Tumor Necrosis Factor Inhibitor
  2.2.2 Interleukin Inhibitors
  2.2.3 Others
2.3 Psoriasis Drugs Market Size by Type
  2.3.1 Psoriasis Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Psoriasis Drugs Market Size Market Share by Type (2019-2024)
2.4 Psoriasis Drugs Segment by Application
  2.4.1 Topicals
  2.4.2 Systemic
  2.4.3 Biologics
2.5 Psoriasis Drugs Market Size by Application
  2.5.1 Psoriasis Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Psoriasis Drugs Market Size Market Share by Application (2019-2024)

3 PSORIASIS DRUGS MARKET SIZE BY PLAYER

3.1 Psoriasis Drugs Market Size Market Share by Players
  3.1.1 Global Psoriasis Drugs Revenue by Players (2019-2024)
  3.1.2 Global Psoriasis Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Psoriasis Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PSORIASIS DRUGS BY REGIONS

4.1 Psoriasis Drugs Market Size by Regions (2019-2024)
4.2 Americas Psoriasis Drugs Market Size Growth (2019-2024)
4.3 APAC Psoriasis Drugs Market Size Growth (2019-2024)
4.4 Europe Psoriasis Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Psoriasis Drugs Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Psoriasis Drugs Market Size by Country (2019-2024)
5.2 Americas Psoriasis Drugs Market Size by Type (2019-2024)
5.3 Americas Psoriasis Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Psoriasis Drugs Market Size by Region (2019-2024)
6.2 APAC Psoriasis Drugs Market Size by Type (2019-2024)
6.3 APAC Psoriasis Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Psoriasis Drugs by Country (2019-2024)
7.2 Europe Psoriasis Drugs Market Size by Type (2019-2024)
7.3 Europe Psoriasis Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Psoriasis Drugs by Region (2019-2024)
8.2 Middle East & Africa Psoriasis Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Psoriasis Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PSORIASIS DRUGS MARKET FORECAST

10.1 Global Psoriasis Drugs Forecast by Regions (2025-2030)
  10.1.1 Global Psoriasis Drugs Forecast by Regions (2025-2030)
  10.1.2 Americas Psoriasis Drugs Forecast
  10.1.3 APAC Psoriasis Drugs Forecast
  10.1.4 Europe Psoriasis Drugs Forecast
  10.1.5 Middle East & Africa Psoriasis Drugs Forecast
10.2 Americas Psoriasis Drugs Forecast by Country (2025-2030)
  10.2.1 United States Psoriasis Drugs Market Forecast
  10.2.2 Canada Psoriasis Drugs Market Forecast
  10.2.3 Mexico Psoriasis Drugs Market Forecast
  10.2.4 Brazil Psoriasis Drugs Market Forecast
10.3 APAC Psoriasis Drugs Forecast by Region (2025-2030)
  10.3.1 China Psoriasis Drugs Market Forecast
  10.3.2 Japan Psoriasis Drugs Market Forecast
  10.3.3 Korea Psoriasis Drugs Market Forecast
  10.3.4 Southeast Asia Psoriasis Drugs Market Forecast
  10.3.5 India Psoriasis Drugs Market Forecast
  10.3.6 Australia Psoriasis Drugs Market Forecast
10.4 Europe Psoriasis Drugs Forecast by Country (2025-2030)
  10.4.1 Germany Psoriasis Drugs Market Forecast
  10.4.2 France Psoriasis Drugs Market Forecast
  10.4.3 UK Psoriasis Drugs Market Forecast
  10.4.4 Italy Psoriasis Drugs Market Forecast
  10.4.5 Russia Psoriasis Drugs Market Forecast
10.5 Middle East & Africa Psoriasis Drugs Forecast by Region (2025-2030)
  10.5.1 Egypt Psoriasis Drugs Market Forecast
  10.5.2 South Africa Psoriasis Drugs Market Forecast
  10.5.3 Israel Psoriasis Drugs Market Forecast
  10.5.4 Turkey Psoriasis Drugs Market Forecast
  10.5.5 GCC Countries Psoriasis Drugs Market Forecast
10.6 Global Psoriasis Drugs Forecast by Type (2025-2030)
10.7 Global Psoriasis Drugs Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 AbbVie
  11.1.1 AbbVie Company Information
  11.1.2 AbbVie Psoriasis Drugs Product Offered
  11.1.3 AbbVie Psoriasis Drugs Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 AbbVie Main Business Overview
  11.1.5 AbbVie Latest Developments
11.2 Amgen
  11.2.1 Amgen Company Information
  11.2.2 Amgen Psoriasis Drugs Product Offered
  11.2.3 Amgen Psoriasis Drugs Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Amgen Main Business Overview
  11.2.5 Amgen Latest Developments
11.3 Johnson & Johnson
  11.3.1 Johnson & Johnson Company Information
  11.3.2 Johnson & Johnson Psoriasis Drugs Product Offered
  11.3.3 Johnson & Johnson Psoriasis Drugs Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Johnson & Johnson Main Business Overview
  11.3.5 Johnson & Johnson Latest Developments
11.4 Novartis
  11.4.1 Novartis Company Information
  11.4.2 Novartis Psoriasis Drugs Product Offered
  11.4.3 Novartis Psoriasis Drugs Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Novartis Main Business Overview
  11.4.5 Novartis Latest Developments
11.5 Eli Lilly & Company
  11.5.1 Eli Lilly & Company Company Information
  11.5.2 Eli Lilly & Company Psoriasis Drugs Product Offered
  11.5.3 Eli Lilly & Company Psoriasis Drugs Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Eli Lilly & Company Main Business Overview
  11.5.5 Eli Lilly & Company Latest Developments
11.6 AstraZeneca
  11.6.1 AstraZeneca Company Information
  11.6.2 AstraZeneca Psoriasis Drugs Product Offered
  11.6.3 AstraZeneca Psoriasis Drugs Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 AstraZeneca Main Business Overview
  11.6.5 AstraZeneca Latest Developments
11.7 Celgene Corporation
  11.7.1 Celgene Corporation Company Information
  11.7.2 Celgene Corporation Psoriasis Drugs Product Offered
  11.7.3 Celgene Corporation Psoriasis Drugs Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Celgene Corporation Main Business Overview
  11.7.5 Celgene Corporation Latest Developments
11.8 UCB
  11.8.1 UCB Company Information
  11.8.2 UCB Psoriasis Drugs Product Offered
  11.8.3 UCB Psoriasis Drugs Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 UCB Main Business Overview
  11.8.5 UCB Latest Developments
11.9 Merck
  11.9.1 Merck Company Information
  11.9.2 Merck Psoriasis Drugs Product Offered
  11.9.3 Merck Psoriasis Drugs Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Merck Main Business Overview
  11.9.5 Merck Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Psoriasis Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players ofTumor NecrosisFactor Inhibitor
Table 3. Major Players of Interleukin Inhibitors
Table 4. Major Players of Others
Table 5. Psoriasis Drugs Market Size CAGR byType (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Psoriasis Drugs Market Size byType (2019-2024) & ($ Millions)
Table 7. Global Psoriasis Drugs Market Size Market Share byType (2019-2024)
Table 8. Psoriasis Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Psoriasis Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Psoriasis Drugs Market Size Market Share by Application (2019-2024)
Table 11. Global Psoriasis Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Psoriasis Drugs Revenue Market Share by Player (2019-2024)
Table 13. Psoriasis Drugs Key Players Head office and Products Offered
Table 14. Psoriasis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Psoriasis Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Psoriasis Drugs Market Size Market Share by Regions (2019-2024)
Table 19. Global Psoriasis Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Psoriasis Drugs Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Psoriasis Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Psoriasis Drugs Market Size Market Share by Country (2019-2024)
Table 23. Americas Psoriasis Drugs Market Size byType (2019-2024) & ($ Millions)
Table 24. Americas Psoriasis Drugs Market Size Market Share byType (2019-2024)
Table 25. Americas Psoriasis Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Psoriasis Drugs Market Size Market Share by Application (2019-2024)
Table 27. APAC Psoriasis Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Psoriasis Drugs Market Size Market Share by Region (2019-2024)
Table 29. APAC Psoriasis Drugs Market Size byType (2019-2024) & ($ Millions)
Table 30. APAC Psoriasis Drugs Market Size Market Share byType (2019-2024)
Table 31. APAC Psoriasis Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Psoriasis Drugs Market Size Market Share by Application (2019-2024)
Table 33. Europe Psoriasis Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Psoriasis Drugs Market Size Market Share by Country (2019-2024)
Table 35. Europe Psoriasis Drugs Market Size byType (2019-2024) & ($ Millions)
Table 36. Europe Psoriasis Drugs Market Size Market Share byType (2019-2024)
Table 37. Europe Psoriasis Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Psoriasis Drugs Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Psoriasis Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Psoriasis Drugs Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Psoriasis Drugs Market Size byType (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Psoriasis Drugs Market Size Market Share byType (2019-2024)
Table 43. Middle East & Africa Psoriasis Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Psoriasis Drugs Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Psoriasis Drugs
Table 46. Key Market Challenges & Risks of Psoriasis Drugs
Table 47. Key IndustryTrends of Psoriasis Drugs
Table 48. Global Psoriasis Drugs Market SizeForecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Psoriasis Drugs Market Size Market ShareForecast by Regions (2025-2030)
Table 50. Global Psoriasis Drugs Market SizeForecast byType (2025-2030) & ($ Millions)
Table 51. Global Psoriasis Drugs Market SizeForecast by Application (2025-2030) & ($ Millions)
Table 52. AbbVie Details, CompanyType, Psoriasis Drugs Area Served and Its Competitors
Table 53. AbbVie Psoriasis Drugs Product Offered
Table 54. AbbVie Psoriasis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. AbbVie Main Business
Table 56. AbbVie Latest Developments
Table 57. Amgen Details, CompanyType, Psoriasis Drugs Area Served and Its Competitors
Table 58. Amgen Psoriasis Drugs Product Offered
Table 59. Amgen Main Business
Table 60. Amgen Psoriasis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Amgen Latest Developments
Table 62. Johnson & Johnson Details, CompanyType, Psoriasis Drugs Area Served and Its Competitors
Table 63. Johnson & Johnson Psoriasis Drugs Product Offered
Table 64. Johnson & Johnson Main Business
Table 65. Johnson & Johnson Psoriasis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Johnson & Johnson Latest Developments
Table 67. Novartis Details, CompanyType, Psoriasis Drugs Area Served and Its Competitors
Table 68. Novartis Psoriasis Drugs Product Offered
Table 69. Novartis Main Business
Table 70. Novartis Psoriasis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Novartis Latest Developments
Table 72. Eli Lilly & Company Details, CompanyType, Psoriasis Drugs Area Served and Its Competitors
Table 73. Eli Lilly & Company Psoriasis Drugs Product Offered
Table 74. Eli Lilly & Company Main Business
Table 75. Eli Lilly & Company Psoriasis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Eli Lilly & Company Latest Developments
Table 77. AstraZeneca Details, CompanyType, Psoriasis Drugs Area Served and Its Competitors
Table 78. AstraZeneca Psoriasis Drugs Product Offered
Table 79. AstraZeneca Main Business
Table 80. AstraZeneca Psoriasis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. AstraZeneca Latest Developments
Table 82. Celgene Corporation Details, CompanyType, Psoriasis Drugs Area Served and Its Competitors
Table 83. Celgene Corporation Psoriasis Drugs Product Offered
Table 84. Celgene Corporation Main Business
Table 85. Celgene Corporation Psoriasis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Celgene Corporation Latest Developments
Table 87. UCB Details, CompanyType, Psoriasis Drugs Area Served and Its Competitors
Table 88. UCB Psoriasis Drugs Product Offered
Table 89. UCB Main Business
Table 90. UCB Psoriasis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. UCB Latest Developments
Table 92. Merck Details, CompanyType, Psoriasis Drugs Area Served and Its Competitors
Table 93. Merck Psoriasis Drugs Product Offered
Table 94. Merck Main Business
Table 95. Merck Psoriasis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Merck Latest Developments

LIST OFFIGURES

Figure 1. Psoriasis Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Psoriasis Drugs Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Psoriasis Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Psoriasis Drugs Sales Market Share by Country/Region (2023)
Figure 8. Psoriasis Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Psoriasis Drugs Market Size Market Share byType in 2023
Figure 10. Psoriasis Drugs inTopicals
Figure 11. Global Psoriasis Drugs Market:Topicals (2019-2024) & ($ Millions)
Figure 12. Psoriasis Drugs in Systemic
Figure 13. Global Psoriasis Drugs Market: Systemic (2019-2024) & ($ Millions)
Figure 14. Psoriasis Drugs in Biologics
Figure 15. Global Psoriasis Drugs Market: Biologics (2019-2024) & ($ Millions)
Figure 16. Global Psoriasis Drugs Market Size Market Share by Application in 2023
Figure 17. Global Psoriasis Drugs Revenue Market Share by Player in 2023
Figure 18. Global Psoriasis Drugs Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Psoriasis Drugs Market Size 2019-2024 ($ Millions)
Figure 20. APAC Psoriasis Drugs Market Size 2019-2024 ($ Millions)
Figure 21. Europe Psoriasis Drugs Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Psoriasis Drugs Market Size 2019-2024 ($ Millions)
Figure 23. Americas Psoriasis Drugs Value Market Share by Country in 2023
Figure 24. United States Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Psoriasis Drugs Market Size Market Share by Region in 2023
Figure 29. APAC Psoriasis Drugs Market Size Market Share byType in 2023
Figure 30. APAC Psoriasis Drugs Market Size Market Share by Application in 2023
Figure 31. China Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Psoriasis Drugs Market Size Market Share by Country in 2023
Figure 38. Europe Psoriasis Drugs Market Size Market Share byType (2019-2024)
Figure 39. Europe Psoriasis Drugs Market Size Market Share by Application (2019-2024)
Figure 40. Germany Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 41.France Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Psoriasis Drugs Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Psoriasis Drugs Market Size Market Share byType (2019-2024)
Figure 47. Middle East & Africa Psoriasis Drugs Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 51.Turkey Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Psoriasis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 54. APAC Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 55. Europe Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 57. United States Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 58. Canada Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 61. China Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 62. Japan Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 63. Korea Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 65. India Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 66. Australia Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 67. Germany Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 68.France Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 69. UK Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 70. Italy Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 71. Russia Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 72. Spain Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 75. Israel Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 76.Turkey Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Psoriasis Drugs Market Size 2025-2030 ($ Millions)
Figure 78. Global Psoriasis Drugs Market Size Market ShareForecast byType (2025-2030)
Figure 79. Global Psoriasis Drugs Market Size Market ShareForecast by Application (2025-2030)